126 related articles for article (PubMed ID: 3912105)
1. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring.
Díaz S; Jackanicz TM; Herreros C; Juez G; Peralta O; Miranda P; Casado ME; Schiapacasse V; Salvatierra AM; Brandeis A
Contraception; 1985 Dec; 32(6):603-22. PubMed ID: 3912105
[TBL] [Abstract][Full Text] [Related]
2. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
[TBL] [Abstract][Full Text] [Related]
3. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
[TBL] [Abstract][Full Text] [Related]
4. The effect of small doses of progesterone released from two types of vaginal rings on ovarian activity and bleeding patterns during the first postpartum year.
Landgren BM; Jonsson B; Cekan SZ
Contraception; 1995 Apr; 51(4):255-60. PubMed ID: 7796592
[TBL] [Abstract][Full Text] [Related]
5. Fertility regulation in nursing women. VI. Contraceptive effectiveness of a subdermal progesterone implant.
Díaz S; Peralta O; Juez G; Herreros C; Casado ME; Salvatierra AM; Miranda P; Croxatto HB
Contraception; 1984 Oct; 30(4):311-25. PubMed ID: 6509984
[TBL] [Abstract][Full Text] [Related]
6. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB
Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703
[TBL] [Abstract][Full Text] [Related]
7. Fertility regulation in nursing women. II. Comparative performance of progesterone implants versus placebo and copper T.
Croxatto HB; Díaz S; Peralta O; Juez G; Casado ME; Salvatierra AM; Durán E
Am J Obstet Gynecol; 1982 Sep; 144(2):201-8. PubMed ID: 7114130
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of progesterone as contraceptive for lactating women.
Díaz S; Miranda P; Brandeis A; Cárdenas H; Croxatto HB
Ann N Y Acad Sci; 1991; 626():11-21. PubMed ID: 2058946
[TBL] [Abstract][Full Text] [Related]
9. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
10. Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review.
Carr SL; Gaffield ME; Dragoman MV; Phillips S
Contraception; 2016 Sep; 94(3):253-61. PubMed ID: 25869631
[TBL] [Abstract][Full Text] [Related]
11. Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.
Roy M; Hazra A; Merkatz R; Plagianos M; Alami M; Gaur LN; Aruldas K; Sussman H; Variano B; Sitruk-Ware R;
Contraception; 2020 Sep; 102(3):159-167. PubMed ID: 32360666
[TBL] [Abstract][Full Text] [Related]
12. Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial.
Massai R; Quinteros E; Reyes MV; Caviedes R; Zepeda A; Montero JC; Croxatto HB
Contraception; 2005 Nov; 72(5):352-7. PubMed ID: 16246661
[TBL] [Abstract][Full Text] [Related]
13. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
Newton J; Szontagh F; Lebech P; Rowe P
Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
[TBL] [Abstract][Full Text] [Related]
14. Vaginal progesterone for contraception.
Victor A; Jackanicz TM; Johansson ED
Fertil Steril; 1978 Dec; 30(6):631-5. PubMed ID: 729823
[TBL] [Abstract][Full Text] [Related]
15. Vaginal rings for contraception in lactating women.
Massai R; Díaz S; Jackanicz T; Croxatto HB
Steroids; 2000; 65(10-11):703-7. PubMed ID: 11108880
[TBL] [Abstract][Full Text] [Related]
16. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
18. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Shaaban MM; Salem HT; Abdullah KA
Contraception; 1985 Dec; 32(6):623-35. PubMed ID: 3937665
[TBL] [Abstract][Full Text] [Related]
19. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
Landgren BM; Hall PE; Cekan SZ
Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366
[TBL] [Abstract][Full Text] [Related]
20. The effect of lactation on ovulation and fertility.
Chao S
Clin Perinatol; 1987 Mar; 14(1):39-50. PubMed ID: 3549114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
